Yasujima Tomoya, Murata Chihiro, Mimura Yoshihisa, Murata Tomoaki, Ohkubo Masahiko, Ohta Kinya, Inoue Katsuhisa, Yuasa Hiroaki
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan.
Physiol Rep. 2018 May;6(10):e13714. doi: 10.14814/phy2.13714.
Sodium-dependent nucleobase transporter 1 (SNBT1) is a nucleobase-specific transporter identified in our recent study. In an attempt to search for its potential substrates other than nucleobases in this study, we could successfully find urate, a metabolic derivative of purine nucleobases, as a novel substrate, as indicated by its specific Na -dependent and saturable transport, with a Michaelis constant of 433 μmol/L, by rat SNBT1 (rSNBT1) stably expressed in Madin-Darby canine kidney II cells. However, urate uptake was observed only barely in the everted tissue sacs of the rat small intestine, in which rSNBT1 operates for nucleobase uptake. These findings suggested that urate undergoes a futile cycle, in which urate transported into epithelial cells is immediately effluxed back by urate efflux transporters, in the small intestine. In subsequent attempts to examine that possibility, such a futile urate cycle was demonstrated in the human embryonic kidney 293 cell line as a model cell system, where urate uptake induced by transiently introduced rSNBT1 was extensively reduced by the co-introduction of rat breast cancer resistance protein (rBCRP), a urate efflux transporter present in the small intestine. However, urate uptake was not raised in the presence of Ko143, a BCRP inhibitor, in the everted intestinal tissue sacs, suggesting that some other transporter might also be involved in urate efflux. The newly found urate transport function of SNBT1, together with the suggested futile urate cycle in the small intestine, should be of interest for its evolutional and biological implications, although SNBT1 is genetically deficient in humans.
钠依赖性核碱基转运体1(SNBT1)是我们最近的研究中鉴定出的一种核碱基特异性转运体。在本研究中,为了寻找除核碱基以外的潜在底物,我们成功发现尿酸(嘌呤核碱基的代谢衍生物)是一种新底物,在稳定表达于Madin-Darby犬肾II细胞中的大鼠SNBT1(rSNBT1)上,其具有特定的钠依赖性和可饱和转运,米氏常数为433μmol/L。然而,在大鼠小肠外翻组织囊中仅观察到极少量的尿酸摄取,而rSNBT1在该组织囊中负责核碱基摄取。这些发现表明,在小肠中尿酸经历了一个无效循环,即转运到上皮细胞中的尿酸会立即被尿酸外排转运体重新外排。在随后检验这种可能性的尝试中,在人胚肾293细胞系这个模型细胞系统中证实了这样一个无效的尿酸循环,在该系统中,瞬时导入的rSNBT1诱导的尿酸摄取会因共同导入大鼠乳腺癌耐药蛋白(rBCRP,一种存在于小肠中的尿酸外排转运体)而大幅降低。然而,在小肠外翻组织囊中,BCRP抑制剂Ko143存在时尿酸摄取并未增加,这表明可能还有其他转运体参与尿酸外排。SNBT1新发现的尿酸转运功能,以及小肠中推测的无效尿酸循环,尽管人类中SNBT1存在基因缺陷,但其进化和生物学意义仍值得关注。